SMALL MOLECULE PREFILLED SYRINGES MARKET ANALYSIS

Small Molecule Prefilled Syringes Market, By Type (Single-chamber Prefilled Syringes, Dual-chamber Prefilled Syringes, and Customized Prefilled Syringes), By Material Type (Glass and Plastic & Polymer), By Application (Diabetes, Cancer, Opthalmology, Anaphylaxis, Rheumatoid Arthritis and Others (Thrombosis, etc.)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Global Small Molecule Prefilled Syringes Market: Key Developments

In June 2022, Elektrofi, a biopharmaceutical company, announced that it had secured funding to support the advancement of candidates based on itsdrug delivery technology into the clinic. By signing deals with companies like Argenx, immunology company and Takeda Pharmaceutical, a pharmaceutical company, had raised US$40 Mn to build a GMP production line and double the workforce.
In September 2021, Lonza, a global pharmaceutical company, announced its plan to invest in additional production capacity for pharmaceuticals in Switzerland. This investment will finance an additional aseptic flexible filling line for clinical drug supply in Stein (CH). The new line supports the filling and processing of liquid and lyophilized bottles as well as cartridges and prefilled syringes. The new filling line will enable Lonza to process various modalities for its customers including monoclonal antibodies, bioconjugates, viral vectors and other gene therapy products.
In May 2020, the U.S. Department of Health and Human Services announced a US$ 138 Mncontract with ApiJect Systems America for “Project Jumpstart” and “RAPID USA,” which together will significantly expand manufacturing capacity for domestically manufactured medical injection devices in the U.S which has begun in October 2020.